21032 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on peptide bonds (3.4) Serine endopeptidases (3.4.21)
Sub-classes:COMPOUNDS FOR PREVENTION AND TREATMENT OF HEMORRHAGE AND VASCULATURE INSTABILITY
#2PROBIOTIC STRAINS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME AND FODMAP INTOLERANCE
#3METHOD FOR THE TREATMENT OF THROMBOEMBOLISM
#4SHEAR RESPONSIVE APTAMER-BASED CONJUGATE FOR TARGETED DRUG DELIVERY
#5COMPOSITIONS AND METHODS FOR TREATING REPERFUSION INJURY OR HEMORRHAGE AFTER RECANALIZATION THERAPY
#6RECOMBINANT CELL WALL HYDROLASES
#7THROMBOLYTIC AND NEURO/VASCULOPROTECTIVE NANOCONJUGATES
#8METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
#9Protease Formulation for Treatment of Toxins
#10HIRUDIN FORMULA COMPOSITION WITH ANTICOAGULANT AND HYPOLIPIDEMIC EFFECTS AND PREPARATION METHOD THEREOF
#11CONTROLLED EXPRESSION OF THERAPEUTICALLY RELEVANT BIOMOLECULES FOR LUMEN-LOCALIZED PAYLOADS IN BIOMIMETIC NANOVESICLES AND EXOSOMES
#12AKKERMANSIA MUCINIPHILA STRAIN AND USE THEREOF
#13Control of Cellular Redox Levels
#14Tissue Modifier And Uses Therefor
#15CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#16ULTRASOUND-MEDIATED GENE THERAPY FOR DEEP VEIN THROMBOSIS AND POST-THROMBOTIC SYNDROME
#17METHODS OF MEDICAL TREATMENT WITH SUR1-TRPM4 CHANNEL INHIBITORS
#18ORAL DOSAGE FORM WITH A GASTRO RESISTANT CAPSULE SHELL
#19TREATMENT FOR AIRWAY CAST OBSTRUCTION
#20NEUROPROTECTIVE POLYPEPTIDE COMPOUND AND APPLICATION THEREOF
#21COMPOSITIONS AND METHODS FOR ENHANCING CARDIOMYOCYTE TRANSPLANT ENGRAFTMENT
#22A METHOD FOR REDUCING AMMONIA EMISSION OF ANIMALS
#23COMPLEMENT FACTOR-I FORMULATIONS
#24Recombinant cell wall hydrolases
#25MAP44 POLYPEPTIDES AND CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF
#26Nanoparticles Having Molecules That Bind or Block PD-L1 and Uses In Treating Cancer
#27MAGNETIC PARTICLE CONTROL AND VISUALIZATION
#28FUNGAL ENZYME MIXTURES AND USES THEREOF
#29DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS
#30MEDICINE COMPOSITION FOR TREATMENT OF BONE AND JOINT DISEASES ORIGINATED FROM MEDICINAL MATERIALS AND THE PROCESS FOR PRODUCING THEREOF
#31COMPOUNDS FOR PREVENTION AND TREATMENT OF HEMORRHAGE AND VASCULATURE INSTABILITY
#32METHODS FOR TREATING INFLAMMATORY AND/OR AUTOIMMUNE SYMPTOMS ASSOCIATED WITH BIOLOGIC AND/OR MRNA VACCINE ADMINISTRATION
#33METHODS OF TREATING ACUTE CORONARY SYNDROME USING 3,3'-DIINDOLYLMETHANE
#34COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED DISORDERS
#35Methods of Treating Cancer and Infectious Diseases Using Cell Based Therapies
#36MODIFIED NEUROTOXIN SINGLE-CHAIN POLYPEPTIDE AND USE THEREOF
#37CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#38Compositions and Methods for Treating Celiac Sprue Disease
#39CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#40FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR TARGETED THROMBOLYTIC THERAPY
#41A PHARMACEUTICALLY ACCEPTABLE AQUEOUS GEL COMPOSITION FOR MRNA DELIVERY
#42Tissue modifier and uses therefor
#43ASPARTIC PROTEASE FOR TREATMENT OF GLUTEN INTOLEREANCE, NUCLEIC ACID MOLECULES ENCODING THE ASPARTIC PROTEASE, METHOD OF PRODUCING THE ASPARTIC PROTEASE, AND APPLICATION THEREOF
#44FUNGAL PROTEASE MIXTURES AND USES THEREOF
#45COMPOSITIONS AND METHODS RELATED TO IMMUNOGLOBULIN PROTEASES AND FUSIONS THEREOF
#46COMBINATION THERAPY FOR TREATMENT OF CONDITIONS ASSOCIATED WITH AGING
#47MODIFIED NEUROTOXIN SINGLE-CHAIN POLYPEPTIDE AND USE THEREOF
#48CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#49FIBRINOGEN AS ADJUVANT FOR ANTIMICROBIAL AGENTS AND THERAPY
#50LYOPHILIZED POLYMER SCAFFOLD COMPOSITIONS, PROCESSES FOR PREPARATION AND USE IN ANABOLIC WOUND REPAIR
#51ENZYMATICALLY INACTIVE GRANZYME A AND USES THEREFORE
#52Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof
#53Reprogramming urokinase into an antibody-recruiting anticancer agent
#54Methods of Treating Ischemic Disease by Administering an ATR Kinase Inhibitor
#55NANOCAPSULE AND USES THEREOF
#56PARAPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITION ADMINISTRABLE TO A LIVING BEING, PREFERABLY A HUMAN BEING, COMPRISING AT LEAST ONE ENZYME FOR THE TREATMENT AND/OR PREVENTION OF BACTERIAL INFECTIONS INVOLVING BIOFILM FORMATION
#57COMPOSITIONS AND METHODS FOR TREATING REPERFUSION INJURY OR HEMORRHAGE AFTER RECANALIZATION THERAPY
#58Nanoparticles having molecules that bind or block PD-L1 and uses in treating cancer
#59COMPOSITION CONTAINING FUNCTIONAL BLACK SOYBEAN POWDER BIOCONVERTED BY USING BACILLUS ENZYMES AS ACTIVE INGREDIENT, AND USE THEREOF
#60Compositions and Methods for the Treatment of Hepatic Diseases and Disorders
#61DEUTERATED RUC-4
#62FIBRINOLYTIC ENZYME COMPOSITION FOR FIBROSIS TREATMENT
#63AGENTS DIRECTED AGAINST A CIS RGMA/NEOGENIN INTERACTION OR LIPID RAFTS AND USE OF THE SAME IN METHODS OF TREATMENT
#64GROUP A STREP IMMUNOGENIC COMPOSITIONS WITH POLYSACCHARIDE-PROTEIN CONJUGATES
#65Treatment delivery system and method
#66INHIBITION OF REPERFUSION INJURY WITH A PSD-95 INHIBITOR
#67ANTIVIRAL AGENT
#68TARGETED DRUG DELIVERY TO SITES OF INTRAVASCULAR OCCLUSION
#69METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
#70FLUID GEL COMPOSITIONS
#71COMPOSITIONS AND METHODS FOR TREATING HAIR FOLLICLE-LINKED CONDITIONS
#72TREATMENT OF THROMBOSIS AND ASSOCIATED DISORDERS WITH AN ANTI-PLATELET AGENT.
#73FLUID GEL COMPOSITIONS
#74DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY
#75PLASMINOGEN FOR USE IN TREATING AND PREVENTING LUNG DYSFUNCTION
#76Compositions And Methods To Reduce And/Or Dissolve Calcium Deposits In Arterial Walls
#77RED BLOOD CELL-DERIVED VESICLE
#78Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane
#79MEDICAL USE OF ICARITIN
#80INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF
#81PROPHYLACTIC USES OF ANNEXIN A2
#82METHODS AND USES FOR PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) INHIBITORS
#83Translatable molecules and synthesis thereof
#84METHODS OF TREATING FRAGILE X SYNDROME WITH REELIN
#85STERICALLY STABILIZED CARRIER FOR AEROSOL THERAPEUTICS, COMPOSITIONS AND METHODS FOR TREATING THE RESPIRATORY TRACT OF A MAMMAL
#86METHODS FOR PREVENTING AND/OR TREATING GERD, HEARTBURN AND/OR GASTROESOPHAGEAL ACID REFLUX
#87Thrombolytic Agents for Intravascular Clots
#88Gene for trypsin-like serine protease, a protein encoded thereby and use thereof
#89DEVICE FOR FIBRIN-BIOPOLYMER-FORMING SUBSTANCE APPLICATION
#90DIFFUSION ENHANCING COMPOUNDS AND THEIR USE ALONE OR WITH THROMBOLYTICS
#91CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#92TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS
#93NANOPARTICLE FOR SPECIFICALLY HYDROLYZING TEMPLATE PROTEIN MOLECULE, AND PREPARATION AND APPLICATION THEREOF
#94THROMBOLYTIC AND NEURO/VASCULOPROTECTIVE NANOCONJUGATES
#95Helicobacter therapeutic
#96Treatment for airway cast obstruction
#97METHODS AND COMPOSITIONS FOR REDUCING IMMUNE RESPONSES AGAINST IMMUNOGLOBULIN PROTEASES
#98METHODS FOR TREATING ARTHRITIS USING SPL-108 PEPTIDE
#99NOVEL HUMANIZED ANTIBODIES AGAINST FACTOR XI HAVING ANTI-THROMBOTIC AND ANTI-INFLAMMATORY EFFECT AND USES THEREOF
#100Extracorporeal devices for methods for treating diseases associated with anti-neutrophil cytoplasmic antibodies
#101Strain for producing nattokinase and production method therefor
#102PHARMACEUTICAL COMPOSITION USING ENDOGENOUS CELLS FOR PREVENTING OR TREATING MUSCULOSKELETAL DISORDERS
#103METHODS OF MEDICAL TREATMENT WITH SUR1-TRPM4 CHANNEL INHIBITORS
#104PEPTIDE DIRECTED PROTEIN KNOCKDOWN
#105Use of prourokinase and its variants against coagulopathy caused by viruses
#106COMPOSITIONS AND METHODS FOR TREATING BONE INJURY
#107FUSOSOME COMPOSITIONS FOR CNS DELIVERY
#108Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane
#109AKKERMANSIA MUCINIPHILA STRAIN AND USE THEREOF
#110BIOMARKERS FOR PREDICTING RISK OF ACUTE ISCHEMIC STROKE AND METHODS OF USE THEREOF
#111Deuterated RUC-4
#112METHODS AND COMPOSITIONS RELATING TO INHIBITING CARDIOVASCULAR CALCIFICATION VIA ANNEXIN A1
#113ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
#114Magnetic particle control and visualization
#115CYTOTOXIC MOLECULES RESPONSIVE TO INTRACELLULAR LIGANDS FOR SELECTIVE T CELL MEDIATED KILLING
#116Nanostructure lipid system
#117Reprogramming urokinase into an antibody-recruiting anticancer agent
#118DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS
#119Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy
#120Treatment of Diseases Related to Hyperactivity of the Complement System
#121Methods of immunotherapy
#122TREATMENT OF AN IOP CONDITION
#123Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#124MAP44 POLYPEPTIDES AND CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF
#125Suppression of bone cancer-induced allodynia
#126CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#127RECOMBINANT FUSION PROTEINS FOR PREVENTING OR TREATING ADHESIONS OF TISSUES OR ORGANS
#128STRUCTURE, MANUFACTURING AND USES OF HUMAN-DERIVED CELL-PERMEABLE PEPTIDES CONJUGATED WITH SPECIFIC BIOLOGICALLY ACTIVE CARGO PEPTIDES
#129Pharmaceutical Composition for Treating Cerebral Infarction
#130NEUTROPHIL ACTIVATION REGULATOR
#131Peptide therapeutics for treating Alzheimer's disease and related conditions
#132COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PROTEINURIA AND ENDOTHELIAL EROSION
#133Compositions and Methods for Treating Celiac Sprue Disease
#134METHODS FOR TREATING FLAVIVIRUSES AND ZIKA INFECTIONS
#135Macrophage stimulating 1 receptor (MST1R) variants and uses thereof
#136SYNTHETIC PLATELETS
#137Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
#138Functionalized microbubble embodiments for ultrasound-mediated treatment and methods of making and using the same
#139Methods of treating inflammatory skin disorders
#140Complement factor B analogs and their uses
#141NANOTHERAPEUTICS FOR DRUG TARGETING
#142Tau protease compositions and methods of use
#143Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis
#144Compositions and methods for thromboembolism dissolution
#145Hsp70 based combination therapy
#146THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOF
#147Nutritional compositions and methods for promoting cognitive development
#148Methods of treating ischemic disease by administering an ATR kinase inhibitor
#149PROTEINS DERIVED FROM CLPB AND USES THEREOF
#150HELICOBACTER THERAPEUTIC
#151Compositions and methods for regulating pancreatic beta cell function using adipsin
#152METHODS OF TREATING CANCER WITH THE COMBINATION OF GRANZYME A GENE DELIVERY AND HSP90 INHIBITION
#153AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
#154METHODS AND COMPOSITIONS FOR MODULATING FGF23 LEVELS
#155Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#156Treatment for airway cast obstruction
#157Materials and methods for delivering compositions to selected tissues
#158Methods of isolating and detecting metal ions from proteins
#159REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS
#160REDUCTION OF EGFR THERAPEUTIC TOXICITY
#161METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
#162Reprogramming urokinase into an antibody-recruiting anticancer agent
#163Treatment and Prophylaxis for Neurological Conditions and Diseases
#164Complement factor B analogs and their uses
#165Method of reducing the effect of a stroke comprising administering an inhibitor of vascular endothelial growth factor B (VEGF-B)
#166Peptide directed protein knockdown
#167Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome
#168Antidotes for factor Xa inhibitors and methods of using the same
#169LATIGLUTENASE (ALV003) FOR USE IN THE TREATMENT OF SYMPTOMATIC CELIAC DISEASE, GLUTEN INTOLERANCE OR GLUTEN SENSITIVITY
#170Mineral salt-sulfonic acid compositions and methods of use
#171TARGET RECOGNITION MOTIFS AND USES THEREOF
#172Compositions and methods for the treatment of hepatic diseases and disorders
#173Agents directed against a cis RGMa/neogenin interaction or lipid rafts and use of the same in methods of treatment
#174Magnetic particle control and visualization
#175Gene vaccine for preventing and treating severe fever with thrombocytopenia syndrome
#176Use of serine protease inhibitors in the treatment of skin diseases
#177Methods of medical treatment with SUR1-TRPM4 channel inhibitors
#178Compositions and methods for treating and preventing proteinuria and endothelial erosion
#179Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
#180Methods of treating cancer using cell based therapies
#181DRUG DELIVERY METHOD
#182Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#183Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#184Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#185SELECTIVE CELL-DEATH-INDUCING BINARY ENZYME SYSTEM
#186Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#187Compositions and methods for treating celiac sprue disease
#188Diffusion enhancing compounds and their use alone or with thrombolytics
#189Methods of treating a subject for a condition
#190Drug delivery means
#191COMPOSITION AND METHOD OF PREPARATION OF PROTEASE MICROPARTICULATE SLOW RELEASE PREPARATION
#192subtilisins, S8A family proteases, as therapeutic enzymes for application in gluten intolerance disorders
#193Devices for controlling magnetic nanoparticles to treat fluid obstructions
#194Compositions and Methods for Treating Metabolic Disorders
#195Translatable molecules and synthesis thereof
#196COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS
#197SYNTHETIC PLATELETS
#198Recombinant batroxobin mixed composition and a hemostatic powder or hemostatic pad comprising same
#199Method of treating stroke by administering a compound that inhibits VEGF-B signaling in combination with a thrombolytic agent
#200Purification process for isolation and commercial production of recombinant TNK-tPA tenecteplase
#201METHOD FOR THE TREATMENT OF THROMBOEMBOLISM
#202Compositions and methods for treating celiac sprue disease
#203Reduction of lipase activity in product formulations
#204Treatment for gastroesophageal reflux disease caused by a neurological disorder
#205Therapeutic compounds and formulations for intranasal delivery
#206Control of Cellular Redox Levels
#207Control of Cellular Redox Levels
#208Control of Cellular Redox Levels
#209Dodecafluoropentane emulsion as a stroke and ischemia therapy
#210Peptides derived from human PCSK9 catalytic domain and uses thereof for promoting LDL-R activity
#211Lipid Nanoparticle Compositions and Methods of Making and Methods of Using the Same
#212Treatment of diseases related to hyperactivity of the complement system
#213Method for improving feed digestibility and growth performance
#214NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES
#215Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing
#216METHOD OF ISOLATING CELLS FROM A TISSUE IN A MAMMAL
#217Compositions and methods for the treatment of hepatic diseases and disorders
#218METHOD FOR PRODUCING MICROPARTICLES
#219Composition and method of preparation of protease microparticulate slow release preparation
#220Compositions and methods for treating celiac sprue disease
#221Methods and materials for identifying and treating mammals having lung adenocarcinoma characterized by neuroendocrine differentiation
#222Recombinant fusion proteins for preventing or treating adhesions of tissues or organs
#223Treatment and prophylaxis for neurological conditions and diseases
#224Antidotes for factor Xa inhibitors and methods of using the same
#225Control of cellular redox levels
#226MAP44 POLYPEPTIDES AND CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF
#227METHODS FOR INHIBITING NEURON APOPTOSIS AND NECROSIS
#228Tau protease compositions and methods of use
#229Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis
#230LYMPHOCYTE MEDIATED DELIVERY OF PROTEINS
#231Treatment and prophylaxis for lupus
#232Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#233Wound debridement compositions containing seaprose and methods of wound treatment using same
#234Magnetic particle control and visualization
#235LACTOFERRIN SUPPLEMENTATION AND DIARRHEA
#236ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE
#237REDUCTION OF EGFR THERAPEUTIC TOXICITY
#238Methods and compositions for immunomodulation
#239Therapeutic magnetic control systems and contrast agents
#240Compositions and methods for regulating pancreatic beta cell function using adipsin
#241Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methods
#242Lyophilized polymer scaffold compositions, processes for preparation and use in anabolic wound repair
#243GRANZYME B PROTEASE VARIANTS
#244Hydrogels of methacrylic hyaluronic acid derivatives for oral enzyme therapy in celiac disease
#245Complement factor B analogs and their uses
#246ENZYMATIC DEBRIDEMENT THERAPY FOR ABNORMAL CELL PROLIFERATION
#247Nutritional compositions and methods for promoting cognitive development
#248Compositions for Relieving the Symptoms of Gluten Sensitivity and Methods of Use Thereof
#249Compositions for in vivo expression of therapeutic sequences in the microbiome
#250Medicament and method for treating innate immune response diseases
#251Synthetic Platelets
#252Gelatinase inhibitors and prodrugs
#253Materials and methods for delivering compositions to selected tissues
#254Modulation of synaptic maintenance
#255Reduction of lipase activity in product formulations
#256Pharmaceutical compositions of tenecteplase
#257Methods for treating cancer by administration of nucleic acids encoding FAP and cancer antigens
#258METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF SKIN DISORDERS
#259Compositions, methods and devices for local drug delivery
#260Use of an acidic soft drink to enhance the efficacy of a gluten-digesting enzyme
#261LACTOFERRIN FOR THE TREATMENT OF IBD ASSOCIATED WITH BACTERIAL INVASION
#262METHOD FOR PRODUCING MICROPARTICLES
#263COMPOSITIONS FOR REDUCING THE DELETERIOUS EFFECTS OF STRESS AND AGING
#264Treatment and Prophylaxis for Parkinson's Disease
#265Integrated infusion container
#266Drug delivery method
#267Compositions and methods for treating celiac sprue disease
#268Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors
#269METHODS AND COMPOSITIONS FOR MODULATING FGF23 LEVELS
#270Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
#271Methods for removing viral contaminants from pancreatic extracts
#272Method of treating gluten intolerance by means of new S8/S53 endopetidases from the actinomycete
#273Polymers for delivery of therapeutic proteins
#274Treatment and prophylaxis for gastroesophageal reflux disease
#275Steroidal nitrones for the treatment and prevention of a cerebral stroke or ischaemia, alzheimer and parkinson disease and amyotrophic lateral sclerosis
#276Cold-adapted protease derived from PAMC 21717 and uses thereof
#277Cold-adapted protease derived from PAMC 21717 and uses thereof
#278Complement factor B analogs and their uses
#279Treatment of cardio-renal disease using PCSK6
#280Therapeutic for treating clostridium difficile infection
#281SELECTIVE CELL-DEATH-INDUCING BINARY ENZYME SYSTEM
#282Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma
#283METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS HAVING LUNG ADENOCARCINOMA CHARACTERIZED BY NEUROENDOCRINE DIFFERENTIATION
#284Hard capsule formulation
#285Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
#286Antidotes for factor XA inhibitors and methods of using the same
#287METHODS AND COMPOSITIONS FOR IMPROVING HEMOSTASIS
#288Treatment of diseases related to hyperactivity of the complement system
#289Method of treating fibrosis in skeletal muscle tissue
#290Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance
#291Drug delivery means
#292GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS
#293Fusion protein comprising granzyme B and use thereof
#294NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES
#295Cosmetic compositions from fish hatching fluid
#296Treatment for airway cast obstruction
#297Process for purifying lactoferrin from milk and products thereof
#298PROTEASE COMPOSITIONS FOR THE TREATMENT OF DAMAGED TISSUE
#299FIBRINOLYTIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF PHLEBOTHROMBOTIC STATES
#300Blends of strains and enzymes